US Patent Issued to Institut National de la Sante et de la Recherche Medicale, Universite Paris-Saclay on March 31 for "Radiomics-based imaging tool to monitor tumor-lymphocyte infiltration and outcome in cancer patients treated by anti-PD-1/PD-L1" (French, American Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,949, issued on March 31, was assigned to Institut National de la Sante et de la Recherche Medicale (Paris) and Universite Paris-Saclay (Gif-sur-Yvette, France).

"Radiomics-based imaging tool to monitor tumor-lymphocyte infiltration and outcome in cancer patients treated by anti-PD-1/PD-L1" was invented by Charles Ferte (Bethesda, Md.), Elaine Johanna Limkin (Cachan, France), Roger Sun (Paris) and Eric Deutsch (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention proposes a radiomics-based biomarker for detecting the presence and the density of tumor infiltrating CD8 T-cells in a solid tumor without having to use any biopsy of ...